REG - Plant Health Care - Plant Health Care--China Distribution with AMVAC

Plant Health CareAnnouncement

16/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240416:nRSP5138Ka&default-theme=true

RNS Number : 5138K  Plant Health Care PLC  16 April 2024

16 April
2024

 

Plant Health Care plc

 ("Plant Health Care" or the "Company")

 

Plant Health Care Announces China Distribution with AMVAC

 

Plant Health Care(®) (AIM.PHC.L), a leading provider of peptides used by
growers to improve crop production and quality within global agricultural
markets, is pleased to announce it has signed a distribution agreement (the
"Agreement") with AMVAC(®), an American Vanguard Company, to support
commercialization of novel fertilizer products in China.

 

Highlights:

-    AMVAC, through its subsidiary in China, will distribute a novel
fertilizer product incorporating PHC's Harpinαβ technology designed for use
within vegetable and row crops to promote plant health and yield.

-    AMVAC continues to evaluate PHC's technology within other markets
including Australia, Central America, and Brazil as novel products to deliver
disease and nematode control in crops such as bananas, potatoes, and soybeans.

 

The Agreement will support commercial sales of the Harpinαβ technology in
combination with a novel AMVAC fertilizer. The first AMVAC product launches to
bring widespread availability of the Harpinαβ technology to growers in China
will occur in 2024. This novel product will help growers improve crop quality
and yield as part of an integrated and environmentally responsible crop
production program.

 

Harpinαβ strengthens the innate immune defense systems common within all
plants in a manner similar to vaccinations in humans, with crops responding
with improved nutrient use efficiency, tolerance to abiotic stress and
ultimately, increased yield and crop quality. Relative to alternative
biological products in the market, Harpinαβ-based products provide highly
consistent product efficacy across a wide range of application and
environmental conditions and is compatible with synthetic fertilizers,
fungicides, herbicides, and insecticides commonly used within commercial
agriculture.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟I am pleased to see our
collaboration with AMVAC result in the launch of an innovative, new product in
China. There is a tremendous opportunity in China for the adoption of
Harpinαβ-based products to support sustainable agriculture. AMVAC has proven
they have the right strategy and the right team in China to drive new product
adoption. We are excited about the upcoming launch later this year. In the
next few years, I fully expect additional products to emerge from the ongoing
collaboration between our companies in China and other high value markets."

 

Lawrence Yu, AMVAC Head of Asia-Pacific Region, said: "AMVAC looks forward to
increasing our biological product offerings in China through this new
partnership with Plant Health Care. We look forward to expanding other
distribution opportunities globally, by utilizing AMVAC's strong market access
across its global footprint."

 

Jim Thompson, Director of Business Development for GreenSolutions at AMVAC,
added: "The Harpinαβ-technology is a proven multi-crop solution that
complements our GreenSolutions portfolio of biological and specialty nutrition
products, which will provide our distribution partners and growers more
flexibility and increased ROI."

 

# # #

 

 

For further information, please contact:

 

 Plant Health Care plc
 Jeff Tweedy, CEO

                                                         Tel: +1 919 926 1600
 Cavendish Capital Markets Limited - Nomad & Broker      Tel: +44 (0) 131 220 9771
 Neil McDonald / Pete Lynch

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, sugarcane, potatoes, rice, and
wheat, as well as specialty crops such as fruits and vegetables. We operate
globally through subsidiaries, distributors, and supply agreements with major
industry partners. Our innovative, patent-protected biological products help
growers to protect their crops from stress and diseases, and to produce higher
quality fruit and vegetables, with a favourable environmental profile. Find
out more at www.planthealthcare.com (http://www.planthealthcare.com/)

 

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural
products company that develops, manufactures, and markets solutions for crop
protection and nutrition, turf and ornamentals management, commercial and
consumer pest control. Over the past 20 years, through product and business
acquisitions, the Company has expanded its operations into 17 countries and
now has over 1,000 product registrations in 56 nations worldwide. Its strategy
rests on three growth initiatives - i) Core Business (through innovation of
conventional products), ii) Green Solutions (with over 130 biorational
products - including fertilizers, microbials, nutritionals and
non-conventional products) and iii) Precision Agriculture innovation
(including SIMPAS prescriptive application and Ultimus measure/record/verify
technologies). American Vanguard is included in the Russell 2000® and Russell
3000® Indexes. To learn more about American Vanguard, please reference the
Company's web site at www.american-vanguard.com
(http://www.american-vanguard.com) .

Agrinos Shanghai is a business of American Vanguard in China. It operates
import, production, and direct distribution in China. Its primary focus is
distribution of AMVAC's GreenSolutions product portfolio and using a technical
sales model focusing on biological solutions with positive returns to growers.
Agrinos China has experienced double-digit growth over the last few years and
has expanded its geographical reach into new territories with China.

.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PRLQLLFFZZLLBBL